Some researchers have also found that anisomycin may enhance tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in kidney cancer cells by downregulating the expressions of Bcl-2, c-FLIP(L), and Mcl-1 (29). This evidence concerns the gene MCL1 and kidney cancer.